TCM
VIE

Tekla Capital Management’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Tekla Capital Management’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-500
Closed -$19K – 225
2020
Q1 		$19K Buy
+500
New +$19.5K ﹤0.01% 215

Other funds holding VIE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tekla Capital Management's VIE Position: Q2 2020 in Review

Tekla Capital Management sold out of Viela Bio, Inc. Common Stock (VIE) in Q2 2020, closing a stake of 500 shares — an estimated $19K sold.

Tekla Capital Management first reported a position in VIE in Q1 2020 and held it in 1 quarter. The position peaked at $19K in Q1 2020. 65 funds tracked by Wall St. Rank hold VIE as of Q2 2020.

  • Tekla Capital Management reported no remaining Viela Bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Tekla Capital Management sold 500 Viela Bio, Inc. Common Stock shares in Q2 2020, an estimated $19K.
  • Tekla Capital Management first reported a position in Viela Bio, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Tekla Capital Management's Viela Bio, Inc. Common Stock position peaked at $19K in Q1 2020.
  • 65 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q2 2020.

Based on Tekla Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.